Norges Bank’s Impax Laboratories, Inc. IPXL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2018
Q2 | – | Sell |
-1,130,781
| Closed | -$22M | – | 2209 |
|
|
2018
Q1 | $22M | Buy |
1,130,781
+233,264
| +26% | +$4.58M | 0.01% | 1369 |
|
|
2017
Q4 | $14.9M | Buy |
897,517
+54,691
| +6% | +$1M | 0.01% | 1595 |
|
|
2017
Q3 | $17.1M | Buy |
842,826
+55,665
| +7% | +$1.06M | 0.01% | 1532 |
|
|
2017
Q2 | $12.7M | Sell |
787,161
-31,753
| -4% | -$469K | 0.01% | 1650 |
|
|
2017
Q1 | $10.4M | Sell |
818,914
-439,122
| -35% | -$5.3M | ﹤0.01% | 1732 |
|
|
2016
Q4 | $16.7M | Buy |
1,258,036
+520,394
| +71% | +$8.9M | 0.01% | 1437 |
|
|
2016
Q3 | $16.7M | Buy |
737,642
+80,071
| +12% | +$2.15M | 0.01% | 1349 |
|
|
2016
Q2 | $19M | Buy |
657,571
+123,147
| +23% | +$4.01M | 0.01% | 1230 |
|
|
2016
Q1 | $17.1M | Hold |
534,424
| – | – | 0.01% | 1255 |
|
|
2015
Q4 | $22.9M | Hold |
534,424
| – | – | 0.01% | 1083 |
|
|
2015
Q3 | $18.8M | Sell |
534,424
-40,574
| -7% | -$1.83M | 0.01% | 1163 |
|
|
2015
Q2 | $26.4M | Sell |
574,998
-32,141
| -5% | -$1.53M | 0.01% | 1018 |
|
|
2015
Q1 | $28.5M | Sell |
607,139
-124,412
| -17% | -$4.95M | 0.01% | 990 |
|
|
2014
Q4 | $23.2M | Hold |
731,551
| – | – | 0.01% | 1118 |
|
|
2014
Q3 | $17.3M | Sell |
731,551
-597,229
| -45% | -$15.3M | 0.01% | 1233 |
|
|
2014
Q2 | $39.9M | Buy |
1,328,780
+621,975
| +88% | +$16.8M | 0.01% | 1166 |
|
|
2014
Q1 | $18.7M | Hold |
706,805
| – | – | 0.01% | 1187 |
|
|
2013
Q4 | $17.8M | Buy |
706,805
+184,258
| +35% | +$4.11M | 0.01% | 1183 |
|
|
2013
Q3 | $10.7M | Buy |
522,547
+194,023
| +59% | +$4.01M | 0.01% | 1514 |
|
|
2013
Q2 | $6.55M | Buy |
+328,524
| New | +$5.83M | ﹤0.01% | 1711 |
|
Norges Bank's IPXL Position: Q2 2018 in Review
Norges Bank sold out of Impax Laboratories, Inc. (IPXL) in Q2 2018, closing a stake of 1,130,781 shares — an estimated $22M sold.
Norges Bank first reported a position in IPXL in Q2 2013 and held it in 20 quarters. The position peaked at $39.9M in Q2 2014. 1 fund tracked by Wall St. Rank holds IPXL as of Q2 2018.
- Norges Bank reported no remaining Impax Laboratories, Inc. position as of Q2 2018 after selling out during the quarter.
- Norges Bank sold 1,130,781 Impax Laboratories, Inc. shares in Q2 2018, an estimated $22M.
- Norges Bank first reported a position in Impax Laboratories, Inc. in Q2 2013 and held it in 20 quarters.
- Norges Bank's Impax Laboratories, Inc. position peaked at $39.9M in Q2 2014.
- 1 fund tracked by Wall St. Rank held Impax Laboratories, Inc. as of Q2 2018.
Based on Norges Bank's 13F filing for Q2 2018, filed 23 Jul 2018.